These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 19352274)
1. Comparative evaluation of Tc-99m cystine and Tc-99m MAG3 in normals and patients with renal functional impairment. Misra M; Pradhan PK; De K; Chandra S; Das BK Clin Nucl Med; 2009 Mar; 34(3):141-5. PubMed ID: 19352274 [TBL] [Abstract][Full Text] [Related]
2. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine. Sohaib M; Rafique A; Saeed S; Afshan A Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132 [TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of Tc-99m cystine. A new renal radiopharmaceutical. Misra M; Das BK; Gambhir S; Mittal BR; Sewatkar AB; Ghosh S; Banerjee SN Clin Nucl Med; 1994 Apr; 19(4):314-20. PubMed ID: 8004863 [TBL] [Abstract][Full Text] [Related]
4. Multicenter trial validation of a camera-based method to measure Tc-99m mercaptoacetyltriglycine, or Tc-99m MAG3, clearance. Taylor A; Manatunga A; Morton K; Reese L; Prato FS; Greenberg E; Folks R; Kemp BJ; Jones ME; Corrigan PE; Galt J; Eshima L Radiology; 1997 Jul; 204(1):47-54. PubMed ID: 9205222 [TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of Tc-99m cystine. A new renal radiopharmaceutical. Misra M; Das BK; Gambhir S; Mittal BR; Sewatkar AB; Ghosh S; Banerjee SN Clin Nucl Med; 1994 May; 19(5):446-51. PubMed ID: 8039322 [TBL] [Abstract][Full Text] [Related]
6. Estimation of technetium-99m-MAG3 renal clearance in children: two gamma camera techniques compared with multiple plasma samples. Gordon I; Anderson PJ; Orton M; Evans K J Nucl Med; 1991 Sep; 32(9):1704-8. PubMed ID: 1831838 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of 99mTc-MAG3-annexin V: influence of the chelate on in vitro and in vivo properties in mice. Vanderheyden JL; Liu G; He J; Patel B; Tait JF; Hnatowich DJ Nucl Med Biol; 2006 Jan; 33(1):135-44. PubMed ID: 16459269 [TBL] [Abstract][Full Text] [Related]
8. Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development. Takahara N; Saga T; Inubushi M; Kusuhara H; Seki C; Ito S; Oyama N; Yokoyama O; Sugiyama Y; Fujibayashi Y Nucl Med Biol; 2013 Jul; 40(5):643-50. PubMed ID: 23618840 [TBL] [Abstract][Full Text] [Related]
10. [Qualitative and quantitative kidney function testing in dogs using MAG3 clearance]. Meyer I; Westhoff A; Meyer-Lindenberg A; Bubeck B; Nolte I Berl Munch Tierarztl Wochenschr; 1997 May; 110(5):185-9. PubMed ID: 9290041 [TBL] [Abstract][Full Text] [Related]
11. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans. Lipowska M; He H; Malveaux E; Xu X; Marzilli LG; Taylor A J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314 [TBL] [Abstract][Full Text] [Related]
12. Exercise acutely increases renal transit time of Tc-99m mercaptoacetyltriglycine (MAG3) in a post-liver transplant patient. Murthy R; Chahal M; Appel G; Bergmann S; Tikofsky R; Fawwaz R; Van Heertum R Clin Nucl Med; 2006 Dec; 31(12):829-34. PubMed ID: 17117088 [TBL] [Abstract][Full Text] [Related]
13. Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function. Taylor A; Ziffer JA; Eshima D Clin Nucl Med; 1990 Jun; 15(6):371-8. PubMed ID: 2141307 [TBL] [Abstract][Full Text] [Related]
14. 99mTc-mercaptoacetyltriglycine camera-based measurement of renal clearance: should the result be normalized for body surface area? Klingensmith WC J Nucl Med Technol; 2013 Dec; 41(4):279-82. PubMed ID: 24167023 [TBL] [Abstract][Full Text] [Related]
15. Factors affecting the hepatobiliary excretion of 99mTc-MAG3: its clinical significance in routine renography. Arroyo AJ; Semaan HB; Minkus KD; Patel YP J Nucl Med Technol; 2003 Mar; 31(1):18-20. PubMed ID: 12624122 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function. Taylor A; Eshima D; Christian PE; Milton W Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212 [TBL] [Abstract][Full Text] [Related]
17. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders. Müller-Suur R; Bois-Svensson I; Mesko L J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371 [TBL] [Abstract][Full Text] [Related]
18. Effects of radiofrequency ablation on individual renal function: assessment by technetium-99m mercaptoacetyltriglycine renal scintigraphy. Mukai T; Sato S; Iguchi T; Mimura H; Yasui K; Gobara H; Saika T; Nasu Y; Kumon H; Kanazawa S Acta Med Okayama; 2006 Apr; 60(2):85-91. PubMed ID: 16680184 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic alteration of (99m)Tc-MAG3 using serum protein binding displacement method. Nishi K; Kobayashi M; Nishii R; Shikano N; Takamura N; Kuga N; Yamasaki K; Nagamachi S; Tamura S; Otagiri M; Kawai K Nucl Med Biol; 2013 Apr; 40(3):366-70. PubMed ID: 23312701 [TBL] [Abstract][Full Text] [Related]
20. The change of the split renal function before and after a nephrectomy using Tc-mercaptoacetyltriglycine (MAG3). Harano M; Tokuda N; Ichikura H; Nakamura M; Eto M; Tatsugami K; Naito S Fukuoka Igaku Zasshi; 2005 Dec; 96(12):391-8. PubMed ID: 16562500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]